ENALAPRILAT DIHYDRATE
PubChem Notes:
Enalaprilat The active metabolite of ENALAPRIL and a potent intravenously administered angiotensin-converting enzyme inhibitor. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion.
Molecular Formula:
C18H28N2O7
InChI: InChI=1/C18H24N2O5.2H2O/c1-12(16(21)15-8-5-11-20(15)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13;;/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25);2*1H2/f/h22,24H;;
InChIKey: InChIKey=LRBNLIUVJIKAQR-MEDLAIHGCO
SMILES: CC(C(=O)C1CCCN1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O.O.O
Names:
ENALAPRILAT DIHYDRATE
L-Proline, 1-(N-(1-carboxy-3-phenylpropyl)-L-alanyl)-, dihydrate, (S)-
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
2-[2-[(1-carboxy-3-phenyl-propyl)amino]propanoyl]pyrrolidine-1-carboxylic acid dihydrate
76420-72-9
84680-54-6
Registries:
PubChem CID 55286
PubChem ID 192758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|